Shijiazhuang Lonzeal Pharmaceuticals Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA.
One of their notable products is TENOFOVIR DISOPROXIL FUMARATE, with a corresponding US DMF Number 35638.
Remarkably, this DMF maintains an Active status since its submission on January 12, 2023, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 03, 2025, and payment made on July 24, 2024, indicating their dedication to facilitating drug approvals, Categorized as Type II